TNF and cancer: We have previously constructed an oncolytic adenovirus coding for human TNFα and IL-2, Ad5/3-E2F-d24-hTNFα-IRES-hIL2 (TILT-123 or igrelimogene litadenorepvec) allowing selective replication in cancer cells and high local expression of these transgenes [3].